Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis

Brain Research Bulletin

Volumn 81, Issue 4-5, 2010, Pages 359-361

  Tang, Bor Luen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Neuron; Neuroprotection; Resveratrol; Sirt1

Indexed keywords

ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; POLYPHENOL; RESVERATROL; SIRTUIN 1; SIRTUIN 1 ACTIVATOR; SIRTUIN 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN DISEASE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXCITOTOXICITY; GENE SILENCING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETTER; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STRESS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BRAIN; CELL DEATH; MODELS, NEUROLOGICAL; NAD; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; SIRTUIN 1; SPINAL CORD; STILBENES;

EID: 74449093522     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.12.007     Document Type: Letter

References (44)

1. Alvira D., Yeste-Velasco M., Folch J., Verdaguer E., Canudas A.M., Pallàs M., et al. Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 147 (2007) 746-756
2. Anekonda T.S. Resveratrol--a boon for treating Alzheimer's disease?. Brain Res Rev 52 (2006) 316-326
3. Bass T.M., Weinkove D., Houthoofd K., Gems D., and Partridge L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 128 (2007) 546-552
4. Baur J.A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
5. Beher D., Wu J., Cumine S., Kim K.W., Lu S.C., Atangan L., et al. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des (2009)
6. Blander G., and Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 73 (2004) 417-435
7. Brisdelli F., D'Andrea G., and Bozzi A. Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab 10 (2009) 530-546
8. Cantó C., and Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20 (2009) 98-105
9. Chang Y., and Wang S.J. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol. Neurochem Int 54 (2009) 135-141
10. Chao J., Yu M.S., Ho Y.S., Wang M., and Chang R.C.C. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic Biol Med 45 (2008) 1019-1026
11. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280 (2005) 40364-40374
12. Chong Z.Z., Lin S.H., Li F., and Maiese K. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways. Curr Neurovasc Res 2 (2005) 271-285
13. Culmsee C., Monnig J., Kemp B.E., and Mattson M.P. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 17 (2001) 45-58
14. Dasgupta B., and Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A 104 (2007) 7217-7222
15. Della-Morte D., Dave K.R., DeFazio R.A., Bao Y.C., Raval A.P., and Perez-Pinzon M.A. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159 (2009) 993-1002
16. Denu J.M. The Sir 2 family of protein deacetylases. Curr Opin Chem Biol 9 (2005) 431-440
17. Gan L., and Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 58 (2008) 10-14
18. Guarente L. Sirtuins in aging and disease. Cold Spring Harb Symp Quant Biol 72 (2007) 483-488
19. Han Y.S., Zheng W.H., Bastianetto S., Chabot J.G., and Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141 (2004) 997-1005
20. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2 (2005) 9-19
21. Holland M.A., Tan A.A., Smith D.C., and Hoane M.R. Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury. J Neurotrauma 25 (2008) 140-152
22. Howitz K.T., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
23. Hwang J.T., Kwak D.W., Lin S.K., Kim H.M., Kim Y.M., and Park O.J. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann N Y Acad Sci 1095 (2007) 441-448
24. Kaeberlein M., et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280 (2005) 17038-17045
25. Kaplan S., Bisleri G., Morgan J.A., Cheema F.H., and Oz M.C. Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg 80 (2005) 2242-2249
26. Kim D., et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26 (2007) 3169-3179
27. Kiziltepe U., Turan N.N.D., Han U., Ulus A.T., and Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 40 (2004) 138-145
28. Li Y., Xu W., McBurney M.W., and Longo V.D. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab 8 (2008) 38-48
29. Liu D., Gharavi R., Pitta M., Gleichmann M., and Mattson M.P. Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med 11 (2009) 28-42
30. Liu D., Pitta M., and Mattson M.P. Preventing NAD(+) depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction. Ann N Y Acad Sci 1147 (2008) 275-282
31. Longo V.D., and Kennedy B.K. Sirtuins in aging and age-related disease. Cell 126 (2006) 257-268
32. Marambaud P., Zhao H., and Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280 (2005) 37377-37382
33. Milne J.C., et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450 (2007) 712-716
34. Nicolini G., Rigolio R., Scuteri A., Miloso M., Saccomanno D., Cavaletti G., et al. Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 42 (2003) 419-429
35. Outeiro T.F., Marques O., and Kazantsev A. Therapeutic role of sirtuins in neurodegenerative disease. Biochim Biophys Acta 1782 (2008) 363-369
36. Parker J.A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H., et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37 (2005) 349-350
37. Raval A.P., Dave K.R., and Pérez-Pinzón M.A. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 26 (2006) 1141-1147
38. Rigolio R., Miloso M., Nicolini G., Villa D., Scuteri A., Simone M., et al. Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis. Neurochem Int 46 (2005) 205-211
39. Smith D.L., Li C., Matecic M., Maqani N., Bryk M., and Smith J.S. Calorie restriction effects on silencing and recombination at the yeast rDNA. Aging Cell 8 (2009) 633-642
40. Tang B.L., and Chua C.E.L. SIRT1 and neuronal diseases. Mol Aspects Med 29 (2008) 187-200
41. Wang R.H., et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14 (2008) 312-323
42. Wang R.H., et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell 32 (2008) 11-20
43. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430 (2004) 686-689
44. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55 (2006) 2180-2191